Can you provide the average price target for ENOVIX CORP stock?
18 analysts have analysed ENVX and the average price target is 24.33 USD. This implies a price increase of 299.46% is expected in the next year compared to the current price of 6.09.
NASDAQ:ENVX • US2935941078
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ENOVIX CORP (ENVX).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-12 | B of A Securities | Initiate | Neutral |
| 2026-02-26 | TD Cowen | Maintains | Hold -> Hold |
| 2026-02-26 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-02-26 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-11-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-11-06 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-11-06 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-08-04 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-07-25 | Benchmark | Maintains | Buy -> Buy |
| 2025-07-24 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-07-10 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-07-08 | Craig-Hallum | Maintains | Buy -> Buy |
| 2025-05-01 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-05-01 | TD Securities | Maintains | Hold -> Hold |
| 2025-04-29 | B. Riley Securities | Maintains | Buy -> Buy |
| 2025-04-24 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-04-15 | Benchmark | Maintains | Buy -> Buy |
| 2025-02-20 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-02-20 | Craig-Hallum | Maintains | Buy -> Buy |
| 2024-10-31 | Janney Montgomery Scott | Downgrade | Buy -> Neutral |
| 2024-10-30 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-10-30 | Benchmark | Reiterate | Buy -> Buy |
| 2024-10-22 | JP Morgan | Maintains | Overweight -> Overweight |
| 2024-08-26 | Oppenheimer | Maintains | Outperform -> Outperform |
| 2024-08-05 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 7.644M 23.29% | 23.074M 201.86% | 31.821M 37.91% | 41.484M 30.37% | 140.52M 238.73% | 527.89M 275.67% | 1.667B 215.79% | 2.467B 47.99% | 1.35B -45.28% | |
| EBITDA YoY % growth | -188.814M -57.83% | -155.901M 17.43% | -141.442M 9.27% | -92.65M 34.50% | -72.23M 22.04% | 97.206M 234.58% | 839.32M 763.44% | 1.205B 43.57% | 469.2M -61.06% | |
| EBIT YoY % growth | -222.823M -75.37% | -200.862M 9.86% | -176.554M 12.10% | -152.8M 13.45% | -142.408M 6.80% | -14.946M 89.50% | 525.56M 3,616.30% | 844.43M 60.67% | 325.58M -61.44% | |
| Operating Margin | -2,915.01% | -870.51% | -554.83% | -368.34% | -101.34% | -2.83% | 31.53% | 34.23% | 24.12% | |
| EPS YoY % growth | -0.86 -43.33% | -0.73 15.12% | -0.56 23.29% | -0.60 -6.96% | -0.52 13.32% | 0.55 206.58% | 2.30 314.75% | 3.28 43.11% | N/A |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.16 -5.78% | -0.15 -16.82% | -0.15 -4.43% | -0.15 -5.64% | -0.15 7.43% | -0.15 4.22% | -0.13 9.44% | -0.15 0.17% | -0.08 44.44% | -0.08 47.41% | -0.05 63.02% | -0.03 79.27% |
| Revenue Q2Q % growth | 7.09M 39.07% | 8.746M 17.11% | 10.699M 33.90% | 14.959M 32.79% | 18.984M 167.76% | 27.65M 216.14% | 41.675M 289.52% | 54.327M 263.17% | 47.869M 152.15% | 53.489M 93.45% | 76.051M 82.49% | 91.984M 69.32% |
| EBITDA Q2Q % growth | -24.561M 28.00% | -25.444M 1.21% | -25.079M -23.55% | -24.561M -176.71% | -30.028M -22.26% | -28.47M -11.90% | -23.859M 4.87% | -19.312M 21.37% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -39.915M 6.21% | -40.438M 6.03% | -39.673M 15.54% | -40.324M 8.33% | -46.856M -17.39% | -48.463M -19.84% | -46.805M -17.98% | -45.683M -13.29% | N/A | N/A | N/A | N/A |
All data in USD
18 analysts have analysed ENVX and the average price target is 24.33 USD. This implies a price increase of 299.46% is expected in the next year compared to the current price of 6.09.
ENOVIX CORP (ENVX) will report earnings on 2026-05-06.
The consensus EPS estimate for the next earnings of ENOVIX CORP (ENVX) is -0.16 USD and the consensus revenue estimate is 7.09M USD.
The consensus rating for ENOVIX CORP (ENVX) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.